66 related articles for article (PubMed ID: 15264240)
1. Mutational analysis of PINX1 in hereditary prostate cancer.
Hawkins GA; Chang BL; Zheng SL; Isaacs SD; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Xu J; Isaacs WB
Prostate; 2004 Sep; 60(4):298-302. PubMed ID: 15264240
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer.
Lindmark F; Jonsson BA; Bergh A; Stattin P; Zheng SL; Meyers DA; Xu J; Grönberg H
Prostate; 2004 May; 59(2):132-40. PubMed ID: 15042613
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
4. Role of HPC2/ELAC2 in hereditary prostate cancer.
Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
Cancer Res; 2001 Sep; 61(17):6494-9. PubMed ID: 11522646
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner AR; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Prostate; 2003 Jun; 56(1):37-44. PubMed ID: 12746845
[TBL] [Abstract][Full Text] [Related]
6. Germ-line alterations in MSR1 gene and prostate cancer risk.
Seppälä EH; Ikonen T; Autio V; Rökman A; Mononen N; Matikainen MP; Tammela TL; Schleutker J
Clin Cancer Res; 2003 Nov; 9(14):5252-6. PubMed ID: 14614006
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of PinX1 in human hepatocellular carcinoma.
Oh BK; Chae KJ; Park C; Park YN
Oncol Rep; 2004 Oct; 12(4):861-6. PubMed ID: 15375513
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma.
Kondo T; Oue N; Mitani Y; Kuniyasu H; Noguchi T; Kuraoka K; Nakayama H; Yasui W
Oncogene; 2005 Jan; 24(1):157-64. PubMed ID: 15637589
[TBL] [Abstract][Full Text] [Related]
9. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
10. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
[TBL] [Abstract][Full Text] [Related]
11. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk.
Zheng SL; Chang BL; Faith DA; Johnson JR; Isaacs SD; Hawkins GA; Turner A; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2002 Nov; 62(22):6485-8. PubMed ID: 12438241
[TBL] [Abstract][Full Text] [Related]
12. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
Vocke CD; Pozzatti RO; Bostwick DG; Florence CD; Jennings SB; Strup SE; Duray PH; Liotta LA; Emmert-Buck MR; Linehan WM
Cancer Res; 1996 May; 56(10):2411-6. PubMed ID: 8625320
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer.
Härkönen P; Kyllönen AP; Nordling S; Vihko P
Prostate; 2005 Feb; 62(3):267-74. PubMed ID: 15389780
[TBL] [Abstract][Full Text] [Related]
14. Frequent germline deletion polymorphism of chromosomal region 8p12-p21 identified as a recurrent homozygous deletion in human tumors.
Ryu B; Song J; Sohn T; Hruban RH; Kern SE
Genomics; 2001 Feb; 72(1):108-12. PubMed ID: 11247673
[TBL] [Abstract][Full Text] [Related]
15. Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk.
Hawkins GA; Mychaleckyj JC; Zheng SL; Faith DA; Kelly B; Isaacs SD; Wiley KE; Chang BL; Ewing CM; Bujnovszky P; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Genet Cytogenet; 2002 Aug; 137(1):1-7. PubMed ID: 12377406
[TBL] [Abstract][Full Text] [Related]
16. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
Hu CK; McCall S; Madden J; Huang H; Clough R; Jirtle RL; Anscher MS
Prostate Cancer Prostatic Dis; 2006; 9(1):62-7. PubMed ID: 16304558
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
19. PinX1: a sought-after major tumor suppressor at human chromosome 8p23.
Zhou XZ
Oncotarget; 2011 Oct; 2(10):810-9. PubMed ID: 22021332
[TBL] [Abstract][Full Text] [Related]
20. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D
Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
